NASDAQ:SLTM - Solta Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Solta Medical, Inc. designs, develops, manufactures and markets professional and consumer energy-based medical device systems for aesthetic applications. The Company's systems are cleared by the United States Food and Drug Administration (FDA) for dermatological procedures performed in the physician led, professional assist, and personal care markets. The Company's portfolio of products includes six brands that are primarily designed for aesthetic applications: The Fraxel re:pair system provides ablative laser skin resurfacing while the non-ablative Fraxel platform and Clear + Brilliant systems provide treatment for skin rejuvenation. The Thermage system provides non-invasive skin tightening and the Liposonix system provides non-invasive body contouring. Isolaz and CLARO provide options to resolve acne. In January 2014, Valeant Pharmaceuticals International Inc 's wholly-owned subsidiary Valeant Pharmaceuticals International acquired Solta Medical Inc.

Receive SLTM News and Ratings via Email

Sign-up to receive the latest news and ratings for SLTM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Current SymbolNASDAQ:SLTM
Previous Symbol
CUSIP83438K10
Phone+1-510-7822286

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Solta Medical (NASDAQ:SLTM) Frequently Asked Questions

What is Solta Medical's stock symbol?

Solta Medical trades on the NASDAQ under the ticker symbol "SLTM."

Has Solta Medical been receiving favorable news coverage?

Media stories about SLTM stock have been trending somewhat negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Solta Medical earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news headlines about the healthcare company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the stock's share price in the near future.

How do I buy shares of Solta Medical?

Shares of SLTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Solta Medical's official website?

The official website for Solta Medical is http://www.solta.com.

How can I contact Solta Medical?

Solta Medical's mailing address is 25881 Industrial Blvd, HAYWARD, CA 94545-2991, United States. The healthcare company can be reached via phone at +1-510-7822286.


MarketBeat Community Rating for Solta Medical (NASDAQ SLTM)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  118 (Vote Outperform)
Underperform Votes:  65 (Vote Underperform)
Total Votes:  183
MarketBeat's community ratings are surveys of what our community members think about Solta Medical and other stocks. Vote "Outperform" if you believe SLTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLTM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel